[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100609274":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":25,"responsibleParty":66,"collaborators":68,"id":71,"slug":72,"hasResults":73,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":77,"eligibilityCriteria":78,"healthyVolunteers":73,"sex":79,"minAge":80,"maxAge":10,"enrollmentInfo":81,"targetDuration":84,"studyType":85,"phases":10,"briefSummary":86,"conditions":87,"keywords":89,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":107,"locationsCount":108},{"fullName":5,"class":6},"Clinica Universidad de Navarra, Universidad de Navarra","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Inpatients",null,"This cohort consists of patients with a confirmed COPD diagnosis who are currently hospitalized due to a severe COPD exacerbation.",{"label":13,"type":10,"description":14,"interventionNames":10},"Outpatients","This cohort includes outpatients with a COPD diagnosis who are being seen for routine follow-up. To be included, these patients must have a history of at least one exacerbation in the past 12 months.",[16,21],{"name":17,"role":18,"phone":19,"phoneExt":10,"email":20},"Carlos J. Chaccour, MD, PhD","CONTACT","+34 666 293 112","cchaccour@unav.es",{"name":22,"role":18,"phone":23,"phoneExt":10,"email":24},"Fhabián S. Carrión-Nessi, MD, MSc","+58 424 958 80 43","fhabiancarrion@gmail.com",[26,45,56],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Clinica San Miguel","RECRUITING","Pamplona","Navarre","31006","Spain","ES",{"type":35,"coordinates":36},"Point",[37,38],-1.64323,42.81687,{"lat":38,"lon":37},[41],{"name":42,"role":18,"phone":43,"phoneExt":10,"email":44},"Dra. Astrid Alvarado, MD","948 296 000","astrid.alvarado@clinicasanmiguel.es",{"facility":46,"status":28,"city":29,"state":30,"zip":47,"country":32,"countryCode":33,"cosmosGeoPoint":48,"geoPoint":50,"contacts":51},"Clínica Universidad de Navarra, Universidad de Navarra","31008",{"type":35,"coordinates":49},[37,38],{"lat":38,"lon":37},[52],{"name":53,"role":18,"phone":54,"phoneExt":10,"email":55},"Juan P. De Torres, MD","+34 948 296 500","jpdetorres@unav.es",{"facility":57,"status":28,"city":29,"state":30,"zip":47,"country":32,"countryCode":33,"cosmosGeoPoint":58,"geoPoint":60,"contacts":61},"Servicio Navarro de Salud",{"type":35,"coordinates":59},[37,38],{"lat":38,"lon":37},[62],{"name":63,"role":18,"phone":64,"phoneExt":10,"email":65},"Francisco J. Bartolomé, MD","+34 609 44 95 78","fjbr@medena.es",{"type":67,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[69],{"name":70,"class":6},"Hyfe Inc","100609274","monitoring-coughs-for-the-early-detection-of-worsening-copd-100609274",false,"NCT07212439","Monitoring Coughs for the Early Detection of Worsening COPD","Continuous Cough Monitoring for Early Detection of COPD Exacerbations Using Hyfe","Hyfe-EPOC","Inclusion criteria:\n\n* Must be 18 years of age or older.\n* Must have an existing diagnosis of COPD.\n* For the inpatient cohort, participants must be currently assessed as having a moderate\u002Fsevere exacerbation.\n* For the outpatient cohort, participants must have had at least one exacerbation of any severity in the last 12 months.\n* For the outpatient cohort, at least one month must have passed since the last exacerbation.\n\nExclusion criteria:\n\n* Individuals who are unable to provide informed consent.\n* Individuals who are unable to adhere to study procedures.\n* For the inpatient cohort, individuals requiring invasive or non-invasive ventilation.\n* Individuals who live with a person who has a chronic cough.","ALL","18 Years",{"count":82,"type":83},50,"ESTIMATED","1 Year","OBSERVATIONAL","This study is for adults with COPD. Flare-ups of COPD, also known as exacerbations, can be serious and lead to hospital stays. The purpose of this research is to see if continuously and automatically monitoring a person's coughs can help predict these flare-ups early, before they become severe. Participants will use the Hyfe cough monitoring system, which includes a watch-like device worn on the wrist and a smartphone application. The system privately counts the number of coughs without recording any audio. Participants will also answer a short, weekly questionnaire about their COPD symptoms. This is an observational study, which means it will not change the regular medical care a participant receives. The participants and their care providers will not see the cough counts. The doctor will continue to manage their COPD as usual.",[88],"Chronic Obstructive Pulmonary Disease (COPD)",[90,91,92,93,94,95,96,97,98],"COPD","COPD Exacerbation","Cough","Cough Monitoring","Hyfe","Early Detection","Wearable Device","Artificial Intelligence","Observational Study","2025-12-30",{"date":101,"type":102},"2026-01-02","ACTUAL",{"date":104,"type":102},"2025-10-29",{"date":106,"type":83},"2026-09",{"name":5,"class":6},3]